EBOS Group Limited (ASX:EBO – Get Free Report) insider Matthew Muscio bought 3,800 shares of the stock in a transaction dated Monday, November 10th. The stock was purchased at an average price of A$28.57 per share, with a total value of A$108,562.20.
EBOS Group Stock Performance
The firm has a market capitalization of $8.20 billion, a P/E ratio of 27.51 and a beta of 0.26. The company has a debt-to-equity ratio of 66.89, a current ratio of 0.95 and a quick ratio of 0.76.
EBOS Group Cuts Dividend
The company also recently announced a Final dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Tuesday, September 23rd were paid a $0.492 dividend. The ex-dividend date was Wednesday, September 3rd. This represents a dividend yield of 168.0%. EBOS Group’s payout ratio is presently 72.14%.
EBOS Group Company Profile
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Featured Articles
- Five stocks we like better than EBOS Group
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Here’s What We Learned From AST SpaceMobile’s Q3 Earnings Report
- Using the MarketBeat Dividend Yield Calculator
- 3 Stocks Quietly Leveraging AI While Everyone Chases NVIDIA
- 3 Warren Buffett Stocks to Buy Now
- LightPath Stock Eyes 50% Upside on Defense Demand Surge
Receive News & Ratings for EBOS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EBOS Group and related companies with MarketBeat.com's FREE daily email newsletter.
